NO20025265L - Regulatorisk nukleinsyre for ABC1-genet, molekyler som modifiserer dets aktivitet og terapautiske anvendelser - Google Patents
Regulatorisk nukleinsyre for ABC1-genet, molekyler som modifiserer dets aktivitet og terapautiske anvendelserInfo
- Publication number
- NO20025265L NO20025265L NO20025265A NO20025265A NO20025265L NO 20025265 L NO20025265 L NO 20025265L NO 20025265 A NO20025265 A NO 20025265A NO 20025265 A NO20025265 A NO 20025265A NO 20025265 L NO20025265 L NO 20025265L
- Authority
- NO
- Norway
- Prior art keywords
- modify
- molecules
- activity
- nucleic acid
- therapeutic applications
- Prior art date
Links
- 101150090313 abc1 gene Proteins 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20128000P | 2000-05-02 | 2000-05-02 | |
| PCT/EP2001/005488 WO2001083746A2 (fr) | 2000-05-02 | 2001-05-02 | Acide nucleique regulateur pour le gene abc1, molecule modifiant son activite et applications therapeutiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20025265D0 NO20025265D0 (no) | 2002-11-01 |
| NO20025265L true NO20025265L (no) | 2002-12-18 |
Family
ID=22745217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20025265A NO20025265L (no) | 2000-05-02 | 2002-11-01 | Regulatorisk nukleinsyre for ABC1-genet, molekyler som modifiserer dets aktivitet og terapautiske anvendelser |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7378274B2 (fr) |
| EP (1) | EP1280911A2 (fr) |
| JP (1) | JP2003531613A (fr) |
| KR (1) | KR20020097242A (fr) |
| AU (1) | AU785155B2 (fr) |
| BR (1) | BR0110541A (fr) |
| CA (1) | CA2407737A1 (fr) |
| FR (1) | FR2809414B1 (fr) |
| IL (1) | IL152548A0 (fr) |
| MX (1) | MXPA02010684A (fr) |
| NO (1) | NO20025265L (fr) |
| NZ (1) | NZ522360A (fr) |
| WO (1) | WO2001083746A2 (fr) |
| ZA (1) | ZA200208847B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2367955C (fr) | 1999-03-15 | 2009-05-19 | University Of British Columbia | Methodes et reactifs permettant de moduler les taux de cholesterol |
| EP1854880A1 (fr) * | 1999-03-15 | 2007-11-14 | University of British Columbia | Procédés et réactifs pour moduler les niveaux de cholestérol |
| CA2375781A1 (fr) * | 1999-06-18 | 2000-12-28 | Cv Therapeutics, Inc. | Compositions et procedes visant a augmenter la sortie de cholesterol et a augmenter la hdl au moyen de la proteine de transport de cassettes de liaison d'atp abc1 |
| US6835563B1 (en) * | 1999-06-18 | 2004-12-28 | Cv Therapeutics | Compositions and methods for increasing cholesterol efflux and raising HDL ATP binding cassette transporter protein ABC1 |
| US6821774B1 (en) * | 1999-06-18 | 2004-11-23 | Cv Therapeutics, Inc. | Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1 |
| AU1291901A (en) * | 1999-09-01 | 2001-03-26 | University Of British Columbia, The | Compositions and methods for modulating hdl cholesterol and triglyceride levels |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5872237A (en) * | 1996-04-04 | 1999-02-16 | Mercator Genetics, Inc. | Megabase transcript map: novel sequences and antibodies thereto |
| CA2367955C (fr) * | 1999-03-15 | 2009-05-19 | University Of British Columbia | Methodes et reactifs permettant de moduler les taux de cholesterol |
| CA2375781A1 (fr) | 1999-06-18 | 2000-12-28 | Cv Therapeutics, Inc. | Compositions et procedes visant a augmenter la sortie de cholesterol et a augmenter la hdl au moyen de la proteine de transport de cassettes de liaison d'atp abc1 |
| AU1291901A (en) * | 1999-09-01 | 2001-03-26 | University Of British Columbia, The | Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| US6773893B1 (en) * | 2000-04-28 | 2004-08-10 | The Trustees Of Columbia University In The City Of New York | Human ABC1 promoter and assays based thereon |
-
2001
- 2001-05-02 WO PCT/EP2001/005488 patent/WO2001083746A2/fr active IP Right Grant
- 2001-05-02 BR BR0110541-8A patent/BR0110541A/pt not_active IP Right Cessation
- 2001-05-02 IL IL15254801A patent/IL152548A0/xx unknown
- 2001-05-02 MX MXPA02010684A patent/MXPA02010684A/es not_active Application Discontinuation
- 2001-05-02 NZ NZ522360A patent/NZ522360A/xx unknown
- 2001-05-02 CA CA002407737A patent/CA2407737A1/fr not_active Abandoned
- 2001-05-02 KR KR1020027014621A patent/KR20020097242A/ko not_active Application Discontinuation
- 2001-05-02 JP JP2001580353A patent/JP2003531613A/ja not_active Withdrawn
- 2001-05-02 FR FR0105886A patent/FR2809414B1/fr not_active Expired - Fee Related
- 2001-05-02 US US09/846,456 patent/US7378274B2/en not_active Expired - Lifetime
- 2001-05-02 AU AU65956/01A patent/AU785155B2/en not_active Ceased
- 2001-05-02 EP EP01943361A patent/EP1280911A2/fr not_active Ceased
-
2002
- 2002-10-31 ZA ZA200208847A patent/ZA200208847B/en unknown
- 2002-11-01 NO NO20025265A patent/NO20025265L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2407737A1 (fr) | 2001-11-08 |
| JP2003531613A (ja) | 2003-10-28 |
| BR0110541A (pt) | 2003-04-01 |
| WO2001083746A3 (fr) | 2002-06-27 |
| FR2809414A1 (fr) | 2001-11-30 |
| AU785155B2 (en) | 2006-10-05 |
| EP1280911A2 (fr) | 2003-02-05 |
| FR2809414B1 (fr) | 2007-08-31 |
| IL152548A0 (en) | 2003-05-29 |
| WO2001083746A2 (fr) | 2001-11-08 |
| NO20025265D0 (no) | 2002-11-01 |
| MXPA02010684A (es) | 2003-03-10 |
| ZA200208847B (en) | 2004-02-09 |
| US7378274B2 (en) | 2008-05-27 |
| US20020146792A1 (en) | 2002-10-10 |
| KR20020097242A (ko) | 2002-12-31 |
| AU6595601A (en) | 2001-11-12 |
| NZ522360A (en) | 2004-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1362027T3 (da) | Acylerede 6,7,8,9-tetrahydro-5H-benzocycloheptenylaminer og deres anvendelse som farmaceutisk middel | |
| NO20034751D0 (no) | Antranilsyreamider, deres fremstilling og anvendelse samt preparater | |
| DK1448591T3 (da) | 17-alpha-alkyl-17-beta-oxy-estratriener og mellemprodukter til fremstilling heraf, anvendelse af 17-alpha-alkyl-17-beta-oxy-estratriener til fremstilling af lægemidler samt farmaceutiske præparater | |
| EE200300369A (et) | Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat | |
| AU4941101A (en) | Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides,and diagnostic and therapeutic methods | |
| EE200300212A (et) | Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks | |
| DE60203018D1 (de) | Katalytischer reaktor | |
| NO20031273L (no) | Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme | |
| NO20041277L (no) | Farmasoytiske preparater for behandling av astma. | |
| AU2002359436A8 (en) | Dna amplification and sequencing using dna molecules generated by random fragmentation | |
| EP2039762A3 (fr) | Nitralases | |
| DE60106864D1 (de) | Katalytisches Krackverfahren | |
| FI20010523A0 (fi) | Soolien, geelien ja niiden seosten käsittely | |
| EP1427746A4 (fr) | Systemes d'expression de proteines et d'acides nucleiques | |
| DK1414809T3 (da) | Indaneddikesyrederivater og anvendelse deraf som farmaceutiske midler, mellemprodukter og fremgangsmåder til fremstilling deraf | |
| NO20026128D0 (no) | Gelformet drivstoff, fremgangsmåte for dets fremstilling og dets anvendelse | |
| NO20041773L (no) | Farmasoytiske preparater for reduksjon av cellers aktivitet samt deres anvendelse. | |
| NO20025265D0 (no) | Regulatorisk nukleinsyre for ABC1-genet, molekyler som modifiserer dets aktivitet og terapautiske anvendelser | |
| DZ3174A1 (fr) | Composition catalytique et procédé utilisant cettecomposition. | |
| NO20041763L (no) | Regulert nukleinsyreekspresjonssystem | |
| BR0212523A2 (pt) | Ácido nucléico, polipeptídeo purificado e seus usos | |
| NO20042137L (no) | Antranilsyreamider og deres farmasoytiske anvendelse | |
| AU2002210661A1 (en) | Nucleic acid generating the ABCA7 gene, molecules modulating its activity and therapeutic applications | |
| ITRM20010670A1 (it) | Piante ricombinanti e costrutti di dna. | |
| WO2002063013A3 (fr) | Nouveau gene de phosphatase acide |